Evidence map›Paper›PMID 35216230›Full record

ArticleInternational journal of molecular sciences2022

Transient Agarose Spot (TAS) Assay: A New Method to Investigate Cell Migration.

Apor Veres-Székely, Domonkos Pap, Beáta Szebeni, László Őrfi, Csenge Szász, Csenge Pajtók, Eszter Lévai, Attila J Szabó, Ádám Vannay

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of molecular sciences · 2024
    Article
  5. Article
  6. High Salt Promotes Inflammatory and Fibrotic Response in Peritoneal Cells.International journal of molecular sciences · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Apor Veres-Székely1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0002-6830-8779
Domonkos Pap1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.
Beáta Szebeni1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.
László ŐrfiDepartment of Pharmaceutical Chemistry, Semmelweis University, 1092 Budapest, Hungary.
Csenge Szász1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.
Csenge Pajtók1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0001-9685-4868
Eszter Lévai1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0002-6149-3254
Attila J Szabó1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.
Ádám Vannay1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.
Semmelweis University · HU

Funding

National Research Development and Innovation Office 2020-4.1.1-TKP2020National Research Development and Innovation Office 20382-3/2018 FEKUTSTRATNational Research Development and Innovation Office FIKP (61830-69271)National Research Development and Innovation Office K124549National Research Development and Innovation Office K125470National Research Development and Innovation Office TKP2020-NKA-09National Research Development and Innovation Office TKP2020-NKA-13Semmelweis University STIA-KFI-2020 (61830-96319)
6 · The paper itself

Abstract

Fibroblasts play a central role in diseases associated with excessive deposition of extracellular matrix (ECM), including idiopathic pulmonary fibrosis. Investigation of different properties of fibroblasts, such as migration, proliferation, and collagen-rich ECM production is unavoidable both in basic research and in the development of antifibrotic drugs. In the present study we developed a cost-effective, 96-well plate-based method to examine the migration of fibroblasts, as an alternative approach to the gold standard scratch assay, which has numerous limitations. This article presents a detailed description of our transient agarose spot (TAS) assay, with instructions for its routine application. Advantages of combined use of different functional assays for fibroblast activation in drug development are also discussed by examining the effect of nintedanib-an FDA approved drug against IPF-on lung fibroblasts.

Indexed as

A549 CellsAnimalsBiological AssayCaco-2 CellsCell LineCell Line, TumorCell MovementCell ProliferationExtracellular MatrixFibroblastsHT29 CellsHumansIdiopathic Pulmonary FibrosisLungRatsSepharoseSepharoseagaroseassaycollagen depositionfibroblasthigh throughputmigrationproliferation

Identifiers

PMID35216230
PMCPMC8880674
OpenAlexW4212783653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.